Forbes September 1, 2021
One of the lasting legacies of Covid-19 was the spotlight that it shone on the U.K.’s rapidly growing genomics industry, currently worth over £5 billion, and raising 34% of the wider U.K. life sciences sector’s total investment, according to the Genomics Nation report. It is a booming industry; just recently, gene-sequencing startup Nanopore was valued at almost £2.5 billion ($3.44 billion) ahead of a planned flotation this year after raising £195 million from investors.
While it was the U.K.’s genomic surveillance of the SARS-CoV-2 virus and its variants that grabbed the media coverage and led the way worldwide throughout the pandemic, behind the news headlines is a hive of innovative activity that promises to make genomics a routine global component...
Today's Sponsors
Today's Sponsor